This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
intensive care | 1644 |
septic shock | 958 |
mechanical ventilation | 894 |
care unit | 850 |
critically ill | 846 |
ill patients | 659 |
patients admitted | 576 |
mortality rate | 536 |
risk factors | 518 |
critical care | 514 |
mean age | 464 |
hospital mortality | 458 |
icu admission | 414 |
two groups | 404 |
cardiac arrest | 396 |
apache ii | 387 |
control group | 366 |
icu stay | 356 |
icu patients | 348 |
acute respiratory | 330 |
respiratory failure | 325 |
mortality rates | 320 |
trauma patients | 313 |
organ failure | 310 |
blood pressure | 300 |
severe sepsis | 290 |
significantly higher | 286 |
ml kg | 284 |
emergency department | 279 |
retrospective study | 269 |
sofa score | 260 |
university hospital | 256 |
mechanically ventilated | 256 |
mg kg | 256 |
respiratory distress | 250 |
observational study | 249 |
cardiac surgery | 246 |
day mortality | 242 |
statistically significant | 240 |
ethics regulations | 238 |
significant difference | 228 |
septic patients | 227 |
cohort study | 227 |
ii score | 222 |
brain injury | 220 |
hospital stay | 218 |
logistic regression | 215 |
care units | 214 |
adult patients | 213 |
study period | 212 |
years old | 206 |
lung injury | 205 |
ng ml | 203 |
renal failure | 202 |
multivariate analysis | 196 |
cardiac output | 194 |
distress syndrome | 192 |
arterial pressure | 189 |
one patient | 189 |
tidal volume | 188 |
significant differences | 187 |
pao fio | 183 |
icu mortality | 182 |
prospective study | 182 |
patients received | 181 |
patients undergoing | 180 |
median age | 177 |
two patients | 177 |
included patients | 173 |
heart rate | 171 |
renal replacement | 167 |
organ dysfunction | 166 |
ventilated patients | 166 |
central venous | 164 |
patients treated | 162 |
replacement therapy | 159 |
traumatic brain | 159 |
statistical analysis | 158 |
kidney injury | 157 |
blood flow | 157 |
saps ii | 156 |
factors associated | 155 |
high mortality | 150 |
arterial blood | 149 |
significantly lower | 147 |
present study | 147 |
acute kidney | 144 |
consecutive patients | 143 |
patients without | 140 |
mean arterial | 140 |
high risk | 139 |
pg ml | 138 |
regression analysis | 138 |
ct scan | 136 |
multiple organ | 136 |
risk factor | 135 |
signifi cant | 135 |
primary outcome | 135 |
higher mortality | 133 |
blood samples | 133 |
antibiotic therapy | 133 |
mg dl | 132 |
signifi cantly | 130 |
critical illness | 128 |
cardiac index | 128 |
among patients | 126 |
within hours | 123 |
prospective observational | 122 |
severity score | 122 |
patients died | 121 |
ards patients | 118 |
heart failure | 117 |
fi rst | 117 |
performed using | 117 |
hospital discharge | 117 |
patients receiving | 116 |
pulmonary artery | 115 |
month period | 113 |
increased mortality | 113 |
shock patients | 112 |
least one | 112 |
inclusion criteria | 112 |
elderly patients | 111 |
body weight | 110 |
independently associated | 110 |
three patients | 110 |
respiratory rate | 109 |
blood gas | 109 |
first hours | 108 |
injury severity | 108 |
icu discharge | 108 |
predictive value | 108 |
year period | 107 |
ml min | 105 |
average age | 105 |
increased risk | 105 |
acute lung | 103 |
retrospective cohort | 103 |
excess mortality | 102 |
univariate analysis | 102 |
overall mortality | 101 |
mortality risk | 101 |
airway pressure | 100 |
cardiogenic shock | 100 |
lactate levels | 99 |
poor outcome | 99 |
abdominal pain | 99 |
systematic review | 99 |
acute renal | 98 |
blood glucose | 98 |
retrospective analysis | 97 |
fl uid | 96 |
blood loss | 96 |
inflammatory response | 96 |
pressure support | 95 |
prognostic factors | 95 |
adverse events | 95 |
myocardial infarction | 94 |
glasgow coma | 94 |
four patients | 93 |
kg min | 93 |
severe ards | 92 |
oxygen saturation | 92 |
associated pneumonia | 92 |
trauma center | 92 |
invasive ventilation | 92 |
surgical patients | 91 |
significant increase | 91 |
head injury | 90 |
patients hospitalized | 90 |
influenza pandemic | 90 |
demographic data | 90 |
surgical treatment | 90 |
reactive protein | 90 |
icu length | 89 |
spontaneous breathing | 89 |
group i | 89 |
public health | 89 |
first days | 89 |
significantly associated | 88 |
patients underwent | 88 |
long term | 88 |
clinical findings | 87 |
odds ratio | 87 |
clinical outcomes | 87 |
confidence interval | 86 |
patients requiring | 86 |
age years | 85 |
gas exchange | 84 |
within days | 83 |
th day | 81 |
randomized controlled | 81 |
clinical practice | 81 |
five patients | 81 |
informed consent | 81 |
clinical characteristics | 80 |
collected data | 80 |
fio ratio | 80 |
emergency surgery | 80 |
hospitalized patients | 80 |
coronary artery | 80 |
mm hg | 79 |
study included | 79 |
postoperative period | 78 |
mortality among | 78 |
health care | 78 |
severe acute | 78 |
membrane oxygenation | 77 |
blood gases | 77 |
measured using | 77 |
patients included | 76 |
prospective cohort | 76 |
diff erence | 76 |
hospital cardiac | 76 |
surgical icu | 75 |
extracorporeal membrane | 75 |
left ventricular | 75 |
care medicine | 75 |
pulmonary embolism | 75 |
independent risk | 74 |
six patients | 74 |
computed tomography | 73 |
plasma levels | 73 |
united states | 73 |
medical icu | 72 |
neurological outcome | 72 |
exclusion criteria | 72 |
endotracheal tube | 72 |
blood transfusion | 72 |
analysis showed | 72 |
survival rate | 71 |
significantly increased | 71 |
roc curve | 70 |
red blood | 70 |
nosocomial infections | 70 |
renal function | 69 |
regression model | 69 |
hospital length | 69 |
receiver operating | 68 |
respiratory system | 68 |
heart disease | 68 |
per patient | 68 |
cause mortality | 68 |
pulmonary disease | 68 |
case history | 67 |
diabetes mellitus | 67 |
stroke volume | 67 |
statistical significance | 66 |
linear regression | 66 |
emergency room | 66 |
invasive mechanical | 66 |
seven patients | 66 |
medical records | 66 |
sex ratio | 66 |
rib fractures | 66 |
year old | 66 |
interquartile range | 65 |
patients aged | 65 |
platelet count | 65 |
ali ards | 65 |
significantly different | 65 |
hemodynamic parameters | 65 |
diff erent | 64 |
controlled trial | 64 |
investigation results | 64 |
severe head | 64 |
coma scale | 64 |
old male | 64 |
oxygen delivery | 64 |
results suggest | 64 |
three groups | 64 |
fluid responsiveness | 64 |
eff ect | 64 |
ischemic stroke | 63 |
specific mortality | 63 |
liver transplantation | 63 |
adverse effects | 62 |
conservative treatment | 62 |
study aimed | 62 |
acute appendicitis | 62 |
blood cultures | 62 |
mean duration | 62 |
nitric oxide | 62 |
fluid resuscitation | 62 |
one case | 62 |
copd patients | 62 |
clinical trials | 61 |
blunt trauma | 61 |
infectious diseases | 61 |
significant decrease | 61 |
side effects | 61 |
patients required | 61 |
systolic blood | 61 |
blood cell | 61 |
significant correlation | 60 |
functional outcome | 60 |
commonly used | 60 |
early diagnosis | 60 |
median time | 60 |
higher risk | 59 |
previous studies | 59 |
chronic obstructive | 59 |
cardiopulmonary bypass | 59 |
kidney disease | 59 |
hospital admission | 59 |
data collection | 59 |
study conducted | 59 |
prognostic value | 59 |
pediatric intensive | 59 |
fluid balance | 59 |
atrial fibrillation | 58 |
general surgery | 58 |
acute phase | 58 |
pulmonary edema | 58 |
patients presented | 58 |
serum creatinine | 58 |
care patients | 58 |
nine patients | 57 |
acute pancreatitis | 57 |
abdominal surgery | 57 |
obstructive pulmonary | 57 |
clinical trial | 57 |
acquired pneumonia | 57 |
study group | 57 |
pseudomonas aeruginosa | 57 |
whole blood | 57 |
ventilatory support | 57 |
small bowel | 56 |
teaching hospital | 56 |
surgical intervention | 56 |
leading cause | 56 |
data suggest | 56 |
hemorrhagic shock | 55 |
physical examination | 55 |
data collected | 55 |
epidemiological transition | 55 |
severity scores | 55 |
secondary outcomes | 55 |
ejection fraction | 54 |
head trauma | 54 |
clinical data | 54 |
cancer patients | 54 |
intracranial hypertension | 54 |
ethics committee | 54 |
patients presenting | 54 |
first day | 54 |
international congresses | 54 |
parenteral nutrition | 53 |
abdominal trauma | 53 |
age group | 53 |
medical intensive | 53 |
blood culture | 53 |
right ventricular | 53 |
prone positioning | 53 |
clinical course | 53 |
mean apache | 52 |
eight patients | 52 |
group ii | 52 |
single center | 52 |
scoring system | 52 |
burn patients | 52 |
standard deviation | 52 |
one hundred | 52 |
life support | 52 |
cardiac function | 52 |
artery bypass | 52 |
pulmonary vascular | 52 |
intracranial pressure | 52 |
patients suffering | 51 |
injured patients | 51 |
case report | 51 |
icu admissions | 51 |
blood lactate | 51 |
venous catheter | 51 |
medical center | 51 |
determine whether | 51 |
vascular resistance | 51 |
may lead | 51 |
analyzed using | 50 |
patient characteristics | 50 |
major trauma | 50 |
predictive factors | 50 |
assessed using | 50 |
acute physiology | 50 |
randomly assigned | 50 |
study showed | 50 |
time points | 50 |
success rate | 50 |
eff ects | 49 |
prone position | 49 |
two cases | 49 |
brain death | 49 |
trauma care | 49 |
total number | 49 |
decision making | 49 |
soft tissue | 49 |
retrospective observational | 49 |
common cause | 49 |
patients developed | 49 |
venous pressure | 49 |
pilot study | 49 |
blood volume | 48 |
vital signs | 48 |
enteral nutrition | 48 |
acute care | 48 |
defi ned | 48 |
tertiary care | 48 |
cardiovascular disease | 48 |
sample size | 48 |
surgical procedures | 48 |
blood cells | 48 |
tidal volumes | 48 |
last years | 48 |
urine output | 48 |
multivariate logistic | 47 |
hemodynamic instability | 47 |
venous blood | 47 |
chest wall | 47 |
failure assessment | 47 |
negative predictive | 47 |
postoperative complications | 47 |
operating characteristic | 47 |
enteral feeding | 47 |
one year | 47 |
poor prognosis | 47 |
prospectively collected | 47 |
identifi ed | 47 |
liver failure | 47 |
respiratory tract | 47 |
fl ow | 47 |
inflammatory mediators | 47 |
per day | 46 |
mean values | 46 |
significantly reduced | 46 |
trauma registry | 46 |
obese patients | 46 |
continuous infusion | 46 |
carbon dioxide | 46 |
united kingdom | 46 |
severe trauma | 46 |
primary endpoint | 46 |
study including | 46 |
surgery patients | 46 |
circulatory failure | 46 |
staphylococcus aureus | 46 |
year mortality | 46 |
expiratory pressure | 46 |
study shows | 46 |
healthy volunteers | 46 |
two different | 46 |
lung cancer | 46 |
blood products | 46 |
general anesthesia | 45 |
antibiotic treatment | 45 |
baseline characteristics | 45 |
medical treatment | 45 |
diff erences | 45 |
risk patients | 45 |
coronavirus disease | 45 |
severe tbi | 44 |
patients showed | 44 |
nosocomial infection | 44 |
doc id | 44 |
fluid administration | 44 |
pulmonary hypertension | 44 |
cord uid | 44 |
respiratory mechanics | 44 |
sofa scores | 44 |
study aims | 44 |
sequential organ | 43 |
oxygen therapy | 43 |
open reduction | 43 |
body mass | 43 |
organ donation | 43 |
postoperative day | 43 |
multiple trauma | 43 |
study population | 43 |
controlled trials | 43 |
bacterial infection | 42 |
clinically relevant | 42 |
increased significantly | 42 |
severe traumatic | 42 |
support ventilation | 42 |
clinical signs | 42 |
internal fixation | 42 |
medical care | 42 |
abdominal wall | 42 |
normal range | 42 |
acute myocardial | 42 |
patient outcomes | 42 |
severely injured | 42 |
correlation coefficient | 42 |
surgical procedure | 41 |
center study | 41 |
systemic inflammation | 41 |
compared using | 41 |
general hospital | 41 |
medical history | 41 |
serum albumin | 41 |
free days | 41 |
identify patients | 41 |
healthy subjects | 41 |
general icu | 41 |
may improve | 41 |
independent predictor | 41 |
oxygen consumption | 41 |
higher incidence | 41 |
lg ml | 41 |
patients may | 41 |
systemic inflammatory | 40 |
hoc analysis | 40 |
ten patients | 40 |
cant diff | 40 |
investigate whether | 40 |
endothelial cells | 40 |
emergency medicine | 40 |
pandemic mortality | 40 |
emergency medical | 40 |
influenza mortality | 39 |
widely used | 39 |
related mortality | 39 |
nursing staff | 39 |
every hours | 39 |
important role | 39 |
airway management | 39 |
infected patients | 39 |
second group | 39 |
patient died | 39 |
mass index | 39 |
studied patients | 39 |
disease severity | 39 |
descriptive study | 39 |
therapeutic hypothermia | 39 |
jugular vein | 38 |
table shows | 38 |
mean length | 38 |
oxidative stress | 38 |
infl ammatory | 38 |
chronic kidney | 38 |
considered significant | 38 |
significant improvement | 38 |
ii scores | 38 |
high morbidity | 38 |
clinical features | 38 |
positive predictive | 38 |
partial pressure | 38 |
may also | 38 |
extubation failure | 38 |
mean time | 38 |
per year | 38 |
significantly decreased | 38 |
patient care | 38 |
cell count | 38 |
exact test | 38 |
internal medicine | 37 |
tissue oxygenation | 37 |
tertiary hospital | 37 |
infectious complications | 37 |
patient population | 37 |
square test | 37 |
aged years | 37 |
time series | 37 |
significant reduction | 37 |
male patients | 37 |
chest trauma | 37 |
three days | 37 |
glasgow outcome | 37 |
sepsis patients | 37 |
differ significantly | 37 |
artery catheter | 37 |
lactate level | 37 |
chest pain | 36 |
prolonged mechanical | 36 |
mortality due | 36 |
predict mortality | 36 |
may help | 36 |
pediatric patients | 36 |
median length | 36 |
serum levels | 36 |
relative risk | 36 |
hemodynamically stable | 36 |
cardiopulmonary resuscitation | 36 |
nervous system | 36 |
patient safety | 36 |
heart surgery | 36 |
preliminary results | 36 |
drotrecogin alfa | 36 |
fluid challenge | 36 |
acute brain | 36 |
median duration | 36 |
white blood | 36 |
complication rate | 36 |
groups according | 35 |
one hour | 35 |
nutritional support | 35 |
older age | 35 |
results indicate | 35 |
old man | 35 |
physiology score | 35 |
acute exacerbation | 35 |
hemodynamic monitoring | 35 |
urinary tract | 35 |
significant association | 35 |
ct scans | 35 |
patients using | 35 |
major cause | 35 |
including patients | 35 |
massive transfusion | 35 |
intubated patients | 35 |
may result | 35 |
clinical outcome | 35 |
operating room | 35 |
positive blood | 35 |
case series | 35 |
antimicrobial therapy | 35 |
lower mortality | 35 |
hip fracture | 35 |
treated patients | 35 |
mean value | 35 |
requiring mechanical | 35 |
metabolic acidosis | 35 |
reduce mortality | 34 |
large number | 34 |
esophageal pressure | 34 |
short term | 34 |
ang ii | 34 |
immune response | 34 |
multicenter study | 34 |
minimally invasive | 34 |
coma score | 34 |
damage control | 34 |
subarachnoid hemorrhage | 34 |
systolic function | 34 |
lung volume | 34 |
respiratory support | 34 |
internal jugular | 34 |
creatinine clearance | 34 |
icu los | 34 |
showed significant | 34 |
cardiovascular diseases | 34 |
emergency departments | 34 |
group compared | 34 |
pulmonary arterial | 34 |
first group | 34 |
supine position | 33 |
endotracheal intubation | 33 |
liver function | 33 |
clinical examination | 33 |
predicted mortality | 33 |
incidence rate | 33 |
medical staff | 33 |
ventilator settings | 33 |
average time | 33 |
whitney test | 33 |
assess whether | 33 |
days mortality | 33 |
analysed using | 33 |
age groups | 33 |
data analysis | 33 |
compartment syndrome | 33 |
acinetobacter baumannii | 33 |
pleural effusion | 33 |
high level | 33 |
tbi patients | 33 |
gene expression | 33 |
post hoc | 33 |
patient outcome | 33 |
determined using | 33 |
high dose | 33 |
retrospective review | 33 |
enrolled patients | 33 |
chest tube | 32 |
died within | 32 |
thoracic trauma | 32 |
scientific studies | 32 |
treatment group | 32 |
simplified acute | 32 |
higher rate | 32 |
early postoperative | 32 |
kg day | 32 |
frequently used | 32 |
gas analysis | 32 |
recent studies | 32 |
femoral artery | 32 |
random effects | 32 |
protective effect | 32 |
acute coronary | 32 |
lung disease | 32 |
controlled study | 31 |
renal dysfunction | 31 |
arterial lactate | 31 |
tissue oxygen | 31 |
mortality associated | 31 |
high flow | 31 |
days vs | 31 |
bronchoalveolar lavage | 31 |
quality improvement | 31 |
niv failure | 31 |
eff ective | 31 |
high levels | 31 |
see table | 31 |
volume expansion | 31 |
muscle weakness | 31 |
day survival | 31 |
icu survivors | 31 |
inpatient mortality | 31 |
support scientific | 31 |
research support | 31 |
pelvic fractures | 31 |
rbc transfusion | 31 |
surgical intensive | 31 |
driving pressure | 31 |
central nervous | 31 |
surface area | 31 |
shockable rhythm | 31 |
high incidence | 31 |
mixed venous | 31 |
tract infection | 31 |
surviving sepsis | 31 |
activated protein | 31 |
first time | 31 |
respiratory syndrome | 31 |
novel coronavirus | 31 |
jugular bulb | 31 |
retrospectively reviewed | 30 |
family members | 30 |
european countries | 30 |
confidence intervals | 30 |
decreased significantly | 30 |
positive end | 30 |
may reduce | 30 |
respiratory diseases | 30 |
tracheal intubation | 30 |
selected patients | 30 |
real time | 30 |
prospectively studied | 30 |
first three | 30 |
aki stage | 30 |
group received | 30 |
prospective randomized | 30 |
patients diagnosed | 30 |
lung water | 30 |
every patient | 30 |
neurologic outcome | 30 |
randomized trial | 30 |
non invasive | 30 |
outcome scale | 30 |
previously reported | 30 |
evaluated using | 30 |
hours later | 30 |
gold standard | 30 |
poverty status | 30 |
polytrauma patients | 30 |
flail chest | 30 |
splenic injury | 30 |
required mechanical | 30 |
spontaneous circulation | 30 |
clinical presentation | 30 |
statistically signifi | 30 |
three different | 30 |
male sex | 30 |
minute ventilation | 30 |
surgical management | 30 |
vasoactive drugs | 30 |
one patients | 30 |
acute abdomen | 29 |
patient underwent | 29 |
even though | 29 |
negative pressure | 29 |
gram negative | 29 |
altman analysis | 29 |
world health | 29 |
liver disease | 29 |
fi ndings | 29 |
old female | 29 |
positive correlation | 29 |
femoral neck | 29 |
identify factors | 29 |
recent years | 29 |
inflammatory cytokines | 29 |
labor market | 29 |
study suggests | 29 |
vena cava | 29 |
cardiac surgical | 29 |
primary objective | 29 |
observational cohort | 29 |
glycemic control | 29 |
inotropic support | 29 |
lung ultrasound | 29 |
high rate | 29 |
increased morbidity | 29 |
monocentric study | 29 |
current study | 29 |
early detection | 29 |
pulse pressure | 29 |
multivariable logistic | 29 |
lower respiratory | 29 |
life expectancy | 29 |
early phase | 29 |
inspiratory pressure | 29 |
major surgery | 29 |
intervention group | 29 |
brain tissue | 29 |
co removal | 29 |
surgical site | 29 |
socioeconomic status | 29 |
cerebral perfusion | 29 |
time spent | 28 |
unfavorable outcome | 28 |
evaluate whether | 28 |
brain damage | 28 |
observation period | 28 |
right heart | 28 |
acute abdominal | 28 |
extravascular lung | 28 |
patients years | 28 |
fi brinogen | 28 |
calculated using | 28 |
case fatality | 28 |
pct levels | 28 |
also found | 28 |
response syndrome | 28 |
continuous renal | 28 |
protective ventilation | 28 |
external fixation | 28 |
crp levels | 28 |
average length | 28 |
citrate anticoagulation | 28 |
standard care | 28 |
weaning failure | 28 |
trauma team | 28 |
related complications | 28 |
ischemic heart | 28 |
included studies | 28 |
beneficial effect | 28 |
four groups | 28 |
ecmo support | 28 |
may contribute | 28 |
discharged alive | 28 |
plasma concentrations | 28 |
older patients | 28 |
analysis revealed | 28 |
patients suffered | 28 |
pulmonary oedema | 27 |
hemodynamic stability | 27 |
patient group | 27 |
general population | 27 |
operative management | 27 |
group showed | 27 |
steady state | 27 |
group without | 27 |
renal disease | 27 |
confi rmed | 27 |
days later | 27 |
cirrhotic patients | 27 |
bacterial infections | 27 |
clinical parameters | 27 |
influenza virus | 27 |
functional status | 27 |
times higher | 27 |
intramedullary nailing | 27 |
control study | 27 |
hand hygiene | 27 |
least hours | 27 |
body temperature | 27 |
renal impairment | 27 |
statistically different | 27 |
delayed diagnosis | 27 |
comorbidity index | 27 |
placebo group | 27 |
improved survival | 27 |
strongly associated | 27 |
may provide | 27 |
flow rate | 27 |
transpulmonary thermodilution | 27 |
organ support | 27 |
medical patients | 27 |
patients needed | 27 |
klebsiella pneumoniae | 27 |
mm patients | 27 |
aspiration pneumonia | 26 |
early identification | 26 |
emergency physicians | 26 |
acute circulatory | 26 |
early mortality | 26 |
group versus | 26 |
retrospectively analyzed | 26 |
organ failures | 26 |
independent predictors | 26 |
term outcome | 26 |
immune system | 26 |
time point | 26 |
remaining patients | 26 |
healthy controls | 26 |
patient demographics | 26 |
clinical decision | 26 |
portal vein | 26 |
necrosis factor | 26 |
spinal cord | 26 |
tissue damage | 26 |
status epilepticus | 26 |
trauma centre | 26 |
cognitive dysfunction | 26 |
penetrating trauma | 26 |
considered statistically | 26 |
bypass grafting | 26 |
transthoracic echocardiography | 26 |
icu staff | 26 |
plateau pressure | 26 |
wistar rats | 26 |
lower extremity | 26 |
negative bacteria | 26 |
left ventricle | 26 |
pediatric trauma | 26 |
first week | 26 |
chronic respiratory | 26 |
stroke patients | 26 |
median icu | 26 |
time period | 26 |
ml vs | 26 |
immunocompromised patients | 26 |
data regarding | 26 |
type i | 26 |
scoring systems | 26 |
bed icu | 26 |
burn injury | 26 |
serum concentrations | 25 |
map mmhg | 25 |
artery pressure | 25 |
mortality ratio | 25 |
cantly higher | 25 |
major complications | 25 |
apache score | 25 |
chronic renal | 25 |
low tidal | 25 |
least days | 25 |
disseminated intravascular | 25 |
trauma centers | 25 |
perfusion pressure | 25 |
statistical difference | 25 |
new york | 25 |
kg hour | 25 |
filtration rate | 25 |
spontaneously breathing | 25 |
level i | 25 |
well known | 25 |
poor outcomes | 25 |
patients ventilated | 25 |
survival rates | 25 |
infl ammation | 25 |
plasma concentration | 25 |
grant acknowledgement | 25 |
base excess | 25 |
flow cytometry | 25 |
common complication | 25 |
income countries | 25 |
breathing trial | 25 |
significantly improved | 25 |
diaphragm dysfunction | 25 |
significant risk | 25 |
tracheostomy tube | 25 |
results show | 25 |
post operative | 25 |
induced lung | 25 |
rank test | 25 |
main causes | 25 |
critical patients | 25 |
undergoing cardiac | 25 |
clinical studies | 25 |
admitted patients | 25 |
ventricular function | 25 |
time course | 24 |
demographic characteristics | 24 |
patients compared | 24 |
mcg kg | 24 |
intravascular coagulation | 24 |
fluid loading | 24 |
dead space | 24 |
outcome measure | 24 |
foreign body | 24 |
infectious disease | 24 |
chi square | 24 |
prospective studies | 24 |
air pollution | 24 |
peripheral blood | 24 |
normal values | 24 |
identified patients | 24 |
postoperative course | 24 |
thrombin generation | 24 |
acute ischemic | 24 |
inhalation injury | 24 |
ex vivo | 24 |
examination revealed | 24 |
regression models | 24 |
coronary angiography | 24 |
closed reduction | 24 |
adrenal insufficiency | 24 |
normal saline | 24 |
arrest patients | 24 |
venous oxygen | 24 |
health problem | 24 |
eligible patients | 24 |
subgroup analysis | 24 |
positive airway | 24 |
severely ill | 24 |
serum lactate | 24 |
death rates | 24 |
france correspondence | 24 |
months later | 24 |
mean icp | 24 |
endothelial cell | 24 |
ventilator associated | 24 |
twelve patients | 24 |
hours post | 24 |
observational studies | 24 |
health organization | 24 |
ill children | 24 |
improve patient | 24 |
reference introduction | 24 |
charlson comorbidity | 24 |
medical university | 24 |
chronic health | 24 |
target range | 24 |
analysis using | 24 |
expiratory flow | 23 |
patient age | 23 |
cerebral blood | 23 |
host response | 23 |
one third | 23 |
nosocomial pneumonia | 23 |
glucose levels | 23 |
articular surface | 23 |
month mortality | 23 |
ivc diameter | 23 |
adverse outcomes | 23 |
human capital | 23 |
ug ml | 23 |
therapeutic management | 23 |
level trauma | 23 |
vascular injury | 23 |
trauma system | 23 |
burned patients | 23 |
main cause | 23 |
ill patient | 23 |
type ii | 23 |
global mortality | 23 |
inflammatory markers | 23 |
respiratory infections | 23 |
also recorded | 23 |
acinetobacter baumanii | 23 |
shaft fractures | 23 |
animal models | 23 |
mental health | 23 |
infusion rate | 23 |
classified according | 23 |
controlled ventilation | 23 |
regional hospital | 23 |
patients within | 23 |
old woman | 23 |
emergency laparotomy | 23 |
low risk | 23 |
mechanical power | 23 |
chest compressions | 23 |
patient admitted | 23 |
care hospital | 23 |
factors related | 23 |
sepsis septic | 23 |
eff ectiveness | 23 |
sepsis campaign | 23 |
arterial oxygen | 23 |
fold higher | 23 |
saps score | 23 |
study performed | 23 |
overall survival | 23 |
high doses | 23 |
grade iii | 23 |
neurological deficit | 23 |
congestive heart | 23 |
abdominal ct | 23 |
bone marrow | 23 |
children aged | 23 |
outcome data | 23 |
multiple regression | 23 |
significant changes | 23 |
bypass surgery | 22 |
fluid therapy | 22 |
th percentile | 22 |
cervical spine | 22 |
hypovolemic shock | 22 |
following parameters | 22 |
good outcome | 22 |
vein thrombosis | 22 |
multidisciplinary team | 22 |
pulmonary infection | 22 |
twenty patients | 22 |
per cent | 22 |
data obtained | 22 |
associated injuries | 22 |
primary care | 22 |
music therapy | 22 |
artery disease | 22 |
clinically significant | 22 |
elective surgery | 22 |
diagnostic accuracy | 22 |
written informed | 22 |
trauma patient | 22 |
first postoperative | 22 |
average duration | 22 |
hospital icu | 22 |
intestinal obstruction | 22 |
underlying disease | 22 |
patient data | 22 |
body surface | 22 |
poor neurological | 22 |
mechanical ventilator | 22 |
flow nasal | 22 |
mortality data | 22 |
receive either | 22 |
emergency care | 22 |
plasminogen activator | 22 |
health status | 22 |
within minutes | 22 |
mg ml | 22 |
multiorgan failure | 22 |
nitrogen balance | 22 |
organ function | 22 |
major abdominal | 22 |
repeated measures | 22 |
pelvic fracture | 22 |
adult icu | 22 |
noninvasive ventilation | 22 |
small sample | 22 |
case reports | 22 |
laboratory tests | 22 |
cell death | 22 |
right ventricle | 22 |
randomized study | 22 |
clinical study | 22 |
cortisol levels | 22 |
risk score | 22 |
loading dose | 22 |
pulse contour | 22 |
animal model | 22 |
mortality prediction | 22 |
mortality compared | 22 |
defined according | 22 |
patients survived | 22 |
excess deaths | 22 |
low dose | 22 |
peep level | 22 |
fluid overload | 22 |
remains unclear | 22 |
continuous variables | 22 |
well tolerated | 22 |
sublingual microcirculation | 22 |
dependent variable | 22 |
machine learning | 21 |
six months | 21 |
pandemic influenza | 21 |
insulin infusion | 21 |
comatose patients | 21 |
inferior vena | 21 |
fatality rate | 21 |
significantly longer | 21 |
economic history | 21 |
took place | 21 |
mean blood | 21 |
higher levels | 21 |
muscle mass | 21 |
missing data | 21 |
diaphragm thickness | 21 |
patients discharged | 21 |
outcome measures | 21 |
pregnant women | 21 |
published data | 21 |
carotid artery | 21 |
iu ml | 21 |
apache iii | 21 |
weight heparin | 21 |
mean follow | 21 |
several studies | 21 |
icu days | 21 |
serious complications | 21 |
respiratory variations | 21 |
care med | 21 |
treated conservatively | 21 |
negative bacilli | 21 |
severe patients | 21 |
significant morbidity | 21 |
small number | 21 |
linear mixed | 21 |
longer duration | 21 |
major role | 21 |
traumatic stress | 21 |
requiring icu | 21 |
patients whose | 21 |
volume index | 21 |
ecmo patients | 21 |
secondary endpoints | 21 |
blood product | 21 |
phase ii | 21 |
remained unchanged | 21 |
organ dysfunctions | 21 |
infl uence | 21 |
group iii | 21 |
cognitive impairment | 21 |
mean saps | 21 |
categorical variables | 21 |
mesenteric ischemia | 21 |
gastrointestinal tract | 21 |
tract infections | 21 |
higher rates | 21 |
group vs | 21 |
fluid bolus | 21 |
year survival | 21 |
less educated | 21 |
term mortality | 21 |
patients met | 21 |
second day | 21 |
vascular permeability | 21 |
traffic accident | 21 |
systemic vascular | 21 |
frozen plasma | 21 |
cardiac dysfunction | 21 |
identify risk | 21 |
term outcomes | 21 |
previous study | 21 |
tissue perfusion | 21 |
myocardial dysfunction | 21 |
abbreviated injury | 21 |
health system | 21 |
making process | 21 |
head injuries | 21 |
iu kg | 21 |
hospital death | 21 |
initial management | 20 |
propensity score | 20 |
tissue injury | 20 |
therapeutic interventions | 20 |
nasogastric tube | 20 |
dysfunction syndrome | 20 |
antibiotic prophylaxis | 20 |
characteristic curve | 20 |
failure rate | 20 |
laboratory findings | 20 |
plasma lactate | 20 |
tumor necrosis | 20 |
admission diagnosis | 20 |
cerebral artery | 20 |
burn center | 20 |
median sofa | 20 |
vt ml | 20 |
general intensive | 20 |
results patients | 20 |
patient groups | 20 |
experimental study | 20 |
mortality patterns | 20 |
frequent cause | 20 |
i trauma | 20 |
female patients | 20 |
clinical variables | 20 |
one month | 20 |
requiring intensive | 20 |
respiratory insufficiency | 20 |
site infection | 20 |
severe brain | 20 |
good correlation | 20 |
syndrome coronavirus | 20 |
sepsis group | 20 |
molecular weight | 20 |
septic complications | 20 |
breathing pattern | 20 |
first months | 20 |
randomized clinical | 20 |
clinical diagnosis | 20 |
distal radius | 20 |
serum samples | 20 |
pelvic ring | 20 |
chart review | 20 |
control groups | 20 |
suspected infection | 20 |
beneficial effects | 20 |
drug resistant | 20 |
polymerase chain | 20 |
bed medical | 20 |
open abdomen | 20 |
hazard ratio | 20 |
community acquired | 20 |
continuous monitoring | 20 |
severe respiratory | 20 |
trauma cases | 20 |
three months | 20 |
oxygen transport | 20 |
future studies | 20 |
acute stroke | 20 |
worse outcomes | 20 |
significantly correlated | 20 |
variables associated | 20 |
growth factor | 20 |
also associated | 20 |
several factors | 20 |
randomised controlled | 20 |
catheter related | 20 |
potential risk | 20 |
thirty patients | 20 |
rapid response | 20 |
life care | 20 |
ca patients | 20 |
past years | 20 |
postoperative care | 20 |
prognostic factor | 20 |
patients submitted | 20 |
kg hr | 20 |
successful weaning | 20 |
clinical condition | 20 |
failure requiring | 20 |
findings suggest | 20 |
trend towards | 20 |
early stage | 20 |
xa activity | 20 |
without significant | 20 |
negative correlation | 20 |
diabetic ketoacidosis | 20 |
control patients | 20 |
diaphragmatic hernia | 20 |
respiratory infection | 20 |
retrospective case | 20 |
two hours | 20 |
cerebral oxygenation | 19 |
mean sd | 19 |
market share | 19 |
undergoing ssrf | 19 |
cardiopulmonary arrest | 19 |
health evaluation | 19 |
patients according | 19 |
clinical conditions | 19 |
clinical status | 19 |
functional outcomes | 19 |
mean hospital | 19 |
trauma mechanism | 19 |
odds ratios | 19 |
four cases | 19 |
predicted body | 19 |
roc curves | 19 |
improve survival | 19 |
supportive care | 19 |
carbon monoxide | 19 |
single centre | 19 |
medical students | 19 |
hospital los | 19 |
oxygenation index | 19 |
hemodynamically unstable | 19 |
thromboembolic diseases | 19 |
ventilation time | 19 |
initial treatment | 19 |
high energy | 19 |
hypoxemic patients | 19 |
hemodynamic variables | 19 |
often associated | 19 |
bloodstream infection | 19 |
healthcare professionals | 19 |
gastric emptying | 19 |
hemodynamic status | 19 |
prothrombin time | 19 |
one week | 19 |
sectional study | 19 |
icu setting | 19 |
transition theory | 19 |
head ct | 19 |
international guidelines | 19 |
chronic liver | 19 |
false positive | 19 |
daily living | 19 |
risk stratification | 19 |
right side | 19 |
low levels | 19 |
trauma surgery | 19 |
median iss | 19 |
isolated bacteria | 19 |
may cause | 19 |
oxygen extraction | 19 |
decompressive craniectomy | 19 |
aki patients | 19 |
volume resuscitation | 19 |
cardiac arrests | 19 |
probably due | 19 |
days post | 19 |
patient presented | 19 |
two days | 19 |
therapeutic intervention | 19 |
neutropenic patients | 19 |
severe complications | 19 |
multivariate regression | 19 |
infection rate | 19 |
electronic medical | 19 |
died due | 19 |
great depression | 19 |
high rates | 19 |
ards group | 19 |
baseline values | 19 |
investigated whether | 19 |
resistant bacteria | 19 |
data show | 19 |
spontaneous ventilation | 19 |
directed therapy | 19 |
external fixator | 19 |
chronic diseases | 19 |
survival analysis | 19 |
ammatory response | 19 |
organ injury | 19 |
chain reaction | 19 |
icu physicians | 19 |
better outcome | 19 |
airway pressures | 19 |
fracture healing | 19 |
remains high | 19 |
excluded patients | 19 |
coronary syndrome | 19 |
stress disorder | 18 |
center retrospective | 18 |
pulmonary function | 18 |
total body | 18 |
main objective | 18 |
weight loss | 18 |
pressure mmhg | 18 |
age range | 18 |
independent factors | 18 |
university hospitals | 18 |
frequent complication | 18 |
prospectively included | 18 |
middle cerebral | 18 |
type diabetes | 18 |
blood transfusions | 18 |
highly significant | 18 |
group patients | 18 |
icu population | 18 |
gestational age | 18 |
nutritional status | 18 |
complications related | 18 |
previously described | 18 |
percutaneous tracheostomy | 18 |
cohort studies | 18 |
injury scale | 18 |
traffic accidents | 18 |
secondary outcome | 18 |
icu readmission | 18 |
preliminary data | 18 |
th century | 18 |
mass casualty | 18 |
transit time | 18 |
serious adverse | 18 |
assessment method | 18 |
systolic arterial | 18 |
high frequency | 18 |
inhaled nitric | 18 |
protocol group | 18 |
operating characteristics | 18 |
younger patients | 18 |
hematological malignancies | 18 |
group treated | 18 |
vessel density | 18 |
liver injury | 18 |
glucose level | 18 |
phase i | 18 |
acetabular fractures | 18 |
using two | 18 |
normal subjects | 18 |
icu nurses | 18 |
patients enrolled | 18 |
male gender | 18 |
two studies | 18 |
york city | 18 |
dawley rats | 18 |
main reason | 18 |
clinical setting | 18 |
routine use | 18 |
mv duration | 18 |
multiple myeloma | 18 |
underwent surgery | 18 |
three times | 18 |
worse prognosis | 18 |
available data | 18 |
hospital care | 18 |
blunt chest | 18 |
life decisions | 18 |
arterial hypertension | 18 |
humeral fractures | 18 |
factors affecting | 18 |
arterial ph | 18 |
skeletal muscle | 18 |
different groups | 18 |
nasal cannula | 18 |
cox model | 18 |
global burden | 18 |
diffi cult | 18 |
peep cmh | 18 |
year follow | 18 |
elective cardiac | 18 |
active bleeding | 18 |
treatment options | 18 |
arterial catheters | 18 |
glomerular filtration | 18 |
bowel obstruction | 18 |
single dose | 18 |
valve replacement | 18 |
venous thrombosis | 18 |
insulin therapy | 18 |
escherichia coli | 18 |
study found | 18 |
neurological complications | 18 |
different types | 18 |
pass success | 17 |
fresh frozen | 17 |
rate among | 17 |
statistical differences | 17 |
current practice | 17 |
tertiary referral | 17 |
injury score | 17 |
prolonged icu | 17 |
mortality inequalities | 17 |
secondary infections | 17 |
preliminary study | 17 |
solid organ | 17 |
acute liver | 17 |
diabetic patients | 17 |
peep levels | 17 |
burn unit | 17 |
tube placement | 17 |
higher apache | 17 |
infection control | 17 |
one study | 17 |
bacterial resistance | 17 |
pk pd | 17 |
vasopressor support | 17 |
cantly lower | 17 |
acquired weakness | 17 |
fibrinogen concentrate | 17 |
venous catheters | 17 |
days following | 17 |
low molecular | 17 |
primary repair | 17 |
death rate | 17 |
many patients | 17 |
patients studied | 17 |
associated risk | 17 |
may occur | 17 |
life threatening | 17 |
angiotensin ii | 17 |
lactic acid | 17 |
stable patients | 17 |
two years | 17 |
i min | 17 |
mainly due | 17 |
maternal mortality | 17 |
invasive procedures | 17 |
phase iii | 17 |
unfractionated heparin | 17 |
fecal peritonitis | 17 |
cardiac failure | 17 |
operative treatment | 17 |
total mortality | 17 |
study patients | 17 |
septic group | 17 |
base deficit | 17 |
sepsis syndrome | 17 |
severe septic | 17 |
death among | 17 |
acute pulmonary | 17 |
early sepsis | 17 |
femoral vein | 17 |
acute mesenteric | 17 |
trend toward | 17 |
median apache | 17 |
venous thromboembolism | 17 |
patients respectively | 17 |
low mortality | 17 |
qsofa score | 17 |
time interval | 17 |
emergency surgical | 17 |
thrombolytic therapy | 17 |
related infections | 17 |
three cases | 17 |
first two | 17 |
hospital survival | 17 |
nerve palsy | 17 |
first pass | 17 |
term survival | 17 |
using spss | 17 |
male patient | 17 |
information system | 17 |
first study | 17 |
predict fluid | 17 |
acquired infections | 17 |
abdominal cavity | 17 |
risk group | 17 |
acute poisoning | 17 |
remained stable | 17 |
grade iv | 17 |
early recognition | 17 |
inhospital mortality | 17 |
liver cirrhosis | 17 |
laboratory data | 17 |
final diagnosis | 17 |
low cardiac | 17 |
trochanteric fractures | 17 |
penetrating abdominal | 17 |
fixed effects | 17 |
wedge pressure | 17 |
curve analysis | 17 |
intensive insulin | 17 |
neuromuscular blockade | 17 |
uid balance | 17 |
within months | 17 |
onset vap | 17 |
pulmonary complications | 17 |
clinical results | 17 |
cord injury | 17 |
predicting mortality | 17 |
emergency service | 17 |
among hospitalized | 17 |
medical service | 17 |
icu day | 17 |
upper extremity | 17 |
much higher | 17 |
healthcare costs | 17 |
undergoing elective | 17 |
reduced mortality | 17 |
invasive aspergillosis | 17 |
viral infection | 17 |
motor vehicle | 17 |
sensitivity analysis | 17 |
mean difference | 17 |
road traffic | 17 |
icu treatment | 17 |
often used | 17 |
right atrium | 17 |
screw fixation | 17 |
ml cmh | 17 |
significant higher | 17 |
old patients | 17 |
may benefit | 17 |
plate osteosynthesis | 16 |
pulmonary tuberculosis | 16 |
wide range | 16 |
survivor group | 16 |
small intestine | 16 |
mg day | 16 |
first attempt | 16 |
electronic health | 16 |
lung compliance | 16 |
depression scale | 16 |
months period | 16 |
developing countries | 16 |
converting enzyme | 16 |
extracorporeal life | 16 |
related factors | 16 |
surgical emergencies | 16 |
per group | 16 |
care admission | 16 |
acute heart | 16 |
past medical | 16 |
induced pulmonary | 16 |
patients experienced | 16 |
seven days | 16 |
antibiotic prescription | 16 |
hiv aids | 16 |
continuous positive | 16 |
following criteria | 16 |
acute severe | 16 |
drug administration | 16 |
amino acids | 16 |
higher among | 16 |
pivotal role | 16 |
lower extremities | 16 |
invasive candidiasis | 16 |
data base | 16 |
patients older | 16 |
organ systems | 16 |
hospitalized covid | 16 |
weaning protocol | 16 |
blood fl | 16 |
ultrasound guidance | 16 |
ventilator days | 16 |
empirical antibiotic | 16 |
induced coagulopathy | 16 |
respiratory effort | 16 |
hepatic encephalopathy | 16 |
early vap | 16 |
lv systolic | 16 |
kdigo criteria | 16 |
tranexamic acid | 16 |
lung elastance | 16 |
routinely used | 16 |
main reasons | 16 |
prediction model | 16 |
constant flow | 16 |
tissue hypoxia | 16 |
first hour | 16 |
natriuretic peptide | 16 |
early pn | 16 |
physiological parameters | 16 |
years period | 16 |
thoracic surgery | 16 |
penetrating injuries | 16 |
initial dose | 16 |
gas flow | 16 |
low doses | 16 |
infection rates | 16 |
clinical use | 16 |
study groups | 16 |
care system | 16 |
male wistar | 16 |
increasingly used | 16 |
significantly elevated | 16 |
ventricular ejection | 16 |
rater reliability | 16 |
electrical activity | 16 |
risk assessment | 16 |
th postoperative | 16 |
care center | 16 |
useful tool | 16 |
fluid management | 16 |
mean total | 16 |
epidemiological characteristics | 16 |
using data | 16 |
four times | 16 |
laboratory parameters | 16 |
rst hours | 16 |
years ago | 16 |
care department | 16 |
cerebral ischemia | 16 |
icu care | 16 |
cerebral oxygen | 16 |
also significantly | 16 |
using standard | 16 |
energy expenditure | 16 |
neck fractures | 16 |
nursing care | 16 |
antibiotic susceptibility | 16 |
lung protective | 16 |
venous return | 16 |
data included | 16 |
higher severity | 16 |
neurological status | 16 |
hospital outcome | 16 |
patients will | 16 |
femoral fracture | 16 |
transfusion requirements | 16 |
months follow | 16 |
response rate | 16 |
rv function | 16 |
without sepsis | 16 |
every day | 16 |
differential diagnosis | 16 |
whole body | 16 |
patient comfort | 16 |
treatment results | 16 |
bloodstream infections | 16 |
non survivors | 16 |
respiratory disease | 16 |
tracheal pressure | 16 |
patients operated | 16 |
glucose control | 16 |
adhesion molecules | 16 |
main results | 16 |
recruitment maneuver | 16 |
early warning | 16 |
following variables | 16 |
better survival | 16 |
results showed | 16 |
unstable patients | 16 |
human albumin | 16 |
surgical technique | 16 |
influenza infection | 16 |
among covid | 16 |
human serum | 16 |
remains controversial | 16 |
higher number | 16 |
among icu | 16 |
icu patient | 16 |
mean airway | 15 |
reactive oxygen | 15 |
prospective data | 15 |
adult trauma | 15 |
randomized trials | 15 |
mean sofa | 15 |
diagnostic criteria | 15 |
lung mechanics | 15 |
severe aecopd | 15 |
total patients | 15 |
young people | 15 |
severe complication | 15 |
mixed effects | 15 |
chest injuries | 15 |
adverse outcome | 15 |
outcomes included | 15 |
standard therapy | 15 |
daily mortality | 15 |
mean icu | 15 |
intravenous infusion | 15 |
regression analyses | 15 |
oleic acid | 15 |
appropriate treatment | 15 |
interval ci | 15 |
poorly understood | 15 |
passive leg | 15 |
ill adults | 15 |
weight bearing | 15 |
tb patients | 15 |
therapeutic strategy | 15 |
multicenter cohort | 15 |
study using | 15 |
partial thromboplastin | 15 |
inspiratory effort | 15 |
icu ventilators | 15 |
femoral head | 15 |
sixteen patients | 15 |
using logistic | 15 |
air bronchogram | 15 |
mean pulmonary | 15 |
serum pct | 15 |
neurological deterioration | 15 |
continuous data | 15 |
postoperative days | 15 |
mortality benefit | 15 |
cerebrospinal fluid | 15 |
mean number | 15 |
complications associated | 15 |
severe hypoxemia | 15 |
ideal body | 15 |
respiratory acidosis | 15 |
experimental sepsis | 15 |
conventional ventilation | 15 |
failure due | 15 |
kidney function | 15 |
literature review | 15 |
lung regions | 15 |
reach statistical | 15 |
cranial trauma | 15 |
blunt abdominal | 15 |
statistical significant | 15 |
patients infected | 15 |
chronic pain | 15 |
clinical experience | 15 |
palliative care | 15 |
lung biopsy | 15 |
hemodynamic measurements | 15 |
care setting | 15 |
alcohol consumption | 15 |
antimicrobial resistance | 15 |
microcirculatory perfusion | 15 |
hospital anxiety | 15 |
important cause | 15 |
anova test | 15 |
brain trauma | 15 |
predictive values | 15 |
period patients | 15 |
candida albicans | 15 |
subclavian vein | 15 |
secondary analysis | 15 |
following icu | 15 |
results obtained | 15 |
weaning process | 15 |
identified using | 15 |
also collected | 15 |
cardiac troponin | 15 |
modifi ed | 15 |
sedative drugs | 15 |
oral anticoagulants | 15 |
patients introduction | 15 |
first episode | 15 |
mixed icu | 15 |
vascular tone | 15 |
control measures | 15 |
postoperative morbidity | 15 |
worse outcome | 15 |
functional results | 15 |
specifi city | 15 |
negative impact | 15 |
positive culture | 15 |
left side | 15 |
line treatment | 15 |
japan introduction | 15 |
smooth muscle | 15 |
reperfusion injury | 15 |
smartcare ps | 15 |
upper gi | 15 |
ganz catheter | 15 |
comparative study | 15 |
log rank | 15 |
study demonstrated | 15 |
pain evaluation | 15 |
significant proportion | 15 |
adult respiratory | 15 |
clinical criteria | 15 |
health outcomes | 15 |
strong correlation | 15 |
four hours | 15 |
retrospective single | 15 |
significant relationship | 15 |
randomly allocated | 15 |
two methods | 15 |
multivariable analysis | 15 |
pain management | 15 |
urea nitrogen | 15 |
per minute | 15 |
important factor | 15 |
deep vein | 15 |
different levels | 15 |
female ratio | 15 |
consecutive adult | 15 |
lactic acidosis | 15 |
study design | 15 |
female sex | 15 |
regional citrate | 15 |
contour analysis | 15 |
thirteen patients | 15 |
five cases | 15 |
explanatory variables | 15 |
cox regression | 15 |
group included | 15 |
least two | 15 |
fatty acids | 15 |
myocardial ischemia | 15 |
first line | 15 |
patient management | 15 |
severe infections | 15 |
invasive method | 15 |
prospective multicenter | 15 |
serum na | 15 |
bronchial secretions | 15 |
month follow | 15 |
children admitted | 15 |
lower limb | 15 |
data concerning | 15 |
hemoglobin level | 15 |
first dose | 15 |
lung tissue | 15 |
care services | 15 |
volume controlled | 15 |
slightly higher | 15 |
literature search | 14 |
good neurological | 14 |
epidural analgesia | 14 |
epidemiological data | 14 |
introduction acute | 14 |
better understanding | 14 |
shock requiring | 14 |
room air | 14 |
ventilation duration | 14 |
induced changes | 14 |
total respiratory | 14 |
underlying malignancy | 14 |
white cell | 14 |
preload responsiveness | 14 |
developed vap | 14 |
packed red | 14 |
noncancer patients | 14 |
end point | 14 |
also noted | 14 |
newly developed | 14 |
favorable neurologic | 14 |
statistical analyses | 14 |
associated factors | 14 |
coronary heart | 14 |
type iii | 14 |
diagnostic performance | 14 |
infant mortality | 14 |
retrospectively analysed | 14 |
biological data | 14 |
temperature management | 14 |
sigmoid volvulus | 14 |
receiving mechanical | 14 |
potential donors | 14 |
uric acid | 14 |
clot formation | 14 |
cd cd | 14 |
trauma centres | 14 |
myocardial injury | 14 |
three years | 14 |
last decades | 14 |
differed significantly | 14 |
femur fractures | 14 |
adverse effect | 14 |
fourteen patients | 14 |
rv lv | 14 |
diagnostic value | 14 |
statistically significantly | 14 |
proximal femoral | 14 |
similar results | 14 |
may represent | 14 |
elevated renin | 14 |
mean score | 14 |
outcomes among | 14 |
wound infection | 14 |
lipid peroxidation | 14 |
clinical suspicion | 14 |
effective treatment | 14 |
organ donors | 14 |
consecutive days | 14 |
peptic ulcer | 14 |
evidence suggests | 14 |
decision support | 14 |
review board | 14 |
care management | 14 |
showed good | 14 |
care team | 14 |
successfully treated | 14 |
treatment groups | 14 |
open heart | 14 |
chest radiograph | 14 |
clinical impact | 14 |
operative complications | 14 |
conventional treatment | 14 |
study demonstrates | 14 |
less likely | 14 |
red cell | 14 |
french icus | 14 |
lps group | 14 |
newly diagnosed | 14 |
stay days | 14 |
ethical committee | 14 |
procedural sedation | 14 |
prehospital setting | 14 |
adverse event | 14 |
pct level | 14 |
data showed | 14 |
two independent | 14 |
exogenous surfactant | 14 |
secondary objective | 14 |
septic animals | 14 |
significant impact | 14 |
sepsis induced | 14 |
immediate postoperative | 14 |
rescue therapy | 14 |
continuous veno | 14 |
multiple logistic | 14 |
ventricular dysfunction | 14 |
cecal ligation | 14 |
massive pulmonary | 14 |
retrospectively collected | 14 |
total hip | 14 |
rat model | 14 |
rank correlation | 14 |
oral care | 14 |
found significant | 14 |
infrared spectroscopy | 14 |
leg raising | 14 |
patients following | 14 |
antimicrobial treatment | 14 |
fracture type | 14 |
function tests | 14 |
northern italy | 14 |
past pandemics | 14 |
care physicians | 14 |
good predictor | 14 |
patient days | 14 |
fluid removal | 14 |
global health | 14 |
patient populations | 14 |
ohca patients | 14 |
median number | 14 |
study based | 14 |
hospital admissions | 14 |
critical ill | 14 |
retrospective chart | 14 |
analysis demonstrated | 14 |
crit care | 14 |
term follow | 14 |
mixed medical | 14 |
therapeutic range | 14 |
healthcare use | 14 |
oxygen supply | 14 |
systolic dysfunction | 14 |
bleeding complications | 14 |
data set | 14 |
pearson correlation | 14 |
patients due | 14 |
following data | 14 |
platelet counts | 14 |
serum concentration | 14 |
antibiotic administration | 14 |
underwent surgical | 14 |
may influence | 14 |
positive results | 14 |
fungal infection | 14 |
hypoxemic respiratory | 14 |
tracheal tube | 14 |
healthy people | 14 |
squared test | 14 |
stem cell | 14 |
pulse oximetry | 14 |
benefi ts | 14 |
south africa | 14 |
hemodynamic effects | 14 |
traumatic injuries | 14 |
study introduction | 14 |
underwent cardiac | 14 |
splenic injuries | 14 |
rate variability | 14 |
inhibitory concentration | 14 |
mortality trends | 14 |
oxygen tension | 14 |
hepatic failure | 14 |
medical team | 14 |
also compared | 14 |
also performed | 14 |
identifi cation | 14 |
postoperative patients | 14 |
direct examination | 14 |
medical record | 14 |
rib fracture | 14 |
bronchogram sign | 14 |
colon anastomosis | 14 |
intravascular volume | 14 |
also showed | 14 |
increased levels | 14 |
improve outcomes | 14 |
significantly greater | 14 |
study protocol | 14 |
longer hospital | 14 |
risk surgical | 14 |
coagulation factors | 14 |
main outcome | 14 |
significant mortality | 14 |
chest radiography | 14 |
weaning criteria | 14 |
liquid chromatography | 14 |
femur fracture | 14 |
term effects | 14 |
early goal | 14 |
general wards | 14 |
analysed data | 14 |
high blood | 14 |
pulmonary contusion | 14 |
pulse rate | 14 |
computerized tomography | 14 |
general anaesthesia | 14 |
fungal infections | 14 |
brain dysfunction | 14 |
adipose tissue | 13 |
inspiratory flow | 13 |
mean iss | 13 |
operative period | 13 |
bone defect | 13 |
endothelial function | 13 |
favorable outcome | 13 |
initial resuscitation | 13 |
retrospective audit | 13 |
hematologic malignancies | 13 |
neutrophil activation | 13 |
bowel sounds | 13 |
icu team | 13 |
binding protein | 13 |
troponin i | 13 |
among critically | 13 |
clinical significance | 13 |
may play | 13 |
early mobilization | 13 |
term exposure | 13 |
blood urea | 13 |
living conditions | 13 |
effects model | 13 |
inspired oxygen | 13 |
acquired infection | 13 |
ankle fractures | 13 |
first year | 13 |
thromboplastin time | 13 |
kidney transplantation | 13 |
cerebral performance | 13 |
two consecutive | 13 |
common practice | 13 |
humeral shaft | 13 |
blood sugar | 13 |
cardiovascular risk | 13 |
stage renal | 13 |
cerebrovascular disease | 13 |
continuously monitored | 13 |
transplant recipients | 13 |
plate fixation | 13 |
hospital acquired | 13 |
benefi cial | 13 |
good results | 13 |
chest compression | 13 |
gas parameters | 13 |
online survey | 13 |
high quality | 13 |
longer icu | 13 |
patients require | 13 |
higher doses | 13 |
whole population | 13 |
activated partial | 13 |
chronic heart | 13 |
venous catheterization | 13 |
care nurse | 13 |
medical surgical | 13 |
solid tumors | 13 |
treatment protocol | 13 |
received mechanical | 13 |
diastolic volume | 13 |
drug monitoring | 13 |
groups i | 13 |
random forest | 13 |
urinary catheter | 13 |
unit patients | 13 |
high grade | 13 |
ct head | 13 |
lower risk | 13 |
particulate matter | 13 |
recombinant human | 13 |
standardized mortality | 13 |
pain score | 13 |
resistant staphylococcus | 13 |
neuromuscular blockers | 13 |
plasma samples | 13 |
hong kong | 13 |
experimental model | 13 |
may develop | 13 |
prognostic models | 13 |
oslo university | 13 |
vegetative state | 13 |
clinical severity | 13 |
aki group | 13 |
blunt splenic | 13 |
national trauma | 13 |
laboratory values | 13 |
advanced age | 13 |
gastrointestinal bleeding | 13 |
allowed us | 13 |
hours following | 13 |
immune responses | 13 |
endothelial damage | 13 |
proximal femur | 13 |
mortality following | 13 |
post traumatic | 13 |
still remains | 13 |
every minutes | 13 |
hiv infection | 13 |
low flow | 13 |
qs qt | 13 |
insulin resistance | 13 |
screening tool | 13 |
also observed | 13 |
early post | 13 |
committee approval | 13 |
per hour | 13 |
ct scanning | 13 |
necrotizing pancreatitis | 13 |
quality control | 13 |
cfu ml | 13 |
open surgery | 13 |
demographic variables | 13 |
injury mechanism | 13 |
identifying patients | 13 |
prowess trial | 13 |
kcal kg | 13 |
year average | 13 |
porcine model | 13 |
acid levels | 13 |
developed septic | 13 |
tube thoracostomy | 13 |
aortic cross | 13 |
traumatic injury | 13 |
clinical manifestations | 13 |
major adverse | 13 |
extracorporeal circulation | 13 |
apache scores | 13 |
performance category | 13 |
last months | 13 |
radial nerve | 13 |
therapeutic drug | 13 |
blood coagulation | 13 |
significantly better | 13 |
igs ii | 13 |
methods used | 13 |
clinical evaluation | 13 |
respiratory depression | 13 |
spiking mortality | 13 |
transesophageal echocardiography | 13 |
candida species | 13 |
serum sodium | 13 |
first period | 13 |
delta pco | 13 |
volume ventilation | 13 |
post cardiac | 13 |
family satisfaction | 13 |
early administration | 13 |
treated surgically | 13 |
surgical emergency | 13 |
descriptive statistics | 13 |
severe infection | 13 |
less severe | 13 |
vascular access | 13 |
primary end | 13 |
immune cells | 13 |
treatment option | 13 |
sodium lactate | 13 |
platelet aggregation | 13 |
patients remains | 13 |
future research | 13 |
renal insufficiency | 13 |
broad spectrum | 13 |
susceptibility testing | 13 |
hospital setting | 13 |
breathing patients | 13 |
lactate clearance | 13 |
gram positive | 13 |
pain intensity | 13 |
pandemic period | 13 |
consecutively admitted | 13 |
dead patients | 13 |
known risk | 13 |
energy trauma | 13 |
institutional review | 13 |
effective method | 13 |
hospital universitario | 13 |
individual patient | 13 |
volume curve | 13 |
mean pao | 13 |
score ii | 13 |
hypercapnic respiratory | 13 |
resuscitation room | 13 |
may impact | 13 |
video laryngoscope | 13 |
hemorrhagic stroke | 13 |
conventional mechanical | 13 |
young patients | 13 |
copd exacerbation | 13 |
hematological malignancy | 13 |
flow oxygen | 13 |
patient required | 13 |
good clinical | 13 |
retrospectively studied | 13 |
common reason | 13 |
baseline measurements | 13 |
urinary output | 13 |
per se | 13 |
total bilirubin | 13 |
emergent surgery | 13 |
pao mmhg | 13 |
new zealand | 13 |
medical literature | 13 |
drug therapy | 13 |
organ damage | 13 |
median value | 13 |
circulatory shock | 13 |
cvd mortality | 13 |
thrombotic complications | 13 |
fl uids | 13 |
inversely correlated | 13 |
refractory cardiac | 13 |
clinical symptoms | 13 |
treated using | 13 |
predict outcome | 13 |
last decade | 13 |
sham group | 13 |
anticoagulant therapy | 13 |
organ system | 13 |
conducted using | 13 |
min vs | 13 |
secondary objectives | 13 |
abdominal injuries | 13 |
influenza vaccination | 13 |
received either | 13 |
haematological malignancy | 13 |
ct findings | 13 |
done using | 13 |
lv dysfunction | 13 |
distal humeral | 12 |
patients scheduled | 12 |
crypt cells | 12 |
requiring renal | 12 |
treatment modality | 12 |
nasal oxygen | 12 |
total parenteral | 12 |
stimulating factor | 12 |
arterial oxygenation | 12 |
analyzed patients | 12 |
major risk | 12 |
much lower | 12 |
population density | 12 |
patients including | 12 |
individual patients | 12 |
ill adult | 12 |
general surgeon | 12 |
activity assay | 12 |
results among | 12 |
recent data | 12 |
lung function | 12 |
early stages | 12 |
anatomical reduction | 12 |
using clinical | 12 |
orotracheal intubation | 12 |
antibiotic use | 12 |
false negative | 12 |
coeffi cient | 12 |
cardiac injury | 12 |
almost half | 12 |
primary survey | 12 |
larger studies | 12 |
sedated patients | 12 |
seventeen patients | 12 |
spectrum antibiotics | 12 |
young adults | 12 |
treat patients | 12 |
good functional | 12 |
immune suppression | 12 |
two pts | 12 |
vascular resistances | 12 |
clot microstructure | 12 |
prognostic marker | 12 |
open lung | 12 |
particle flow | 12 |
year study | 12 |
bypass graft | 12 |
antithrombotic drugs | 12 |
medical conditions | 12 |
cell surface | 12 |
mann whitney | 12 |
significant change | 12 |
study comparing | 12 |
combination therapy | 12 |
one day | 12 |
performed within | 12 |
performance status | 12 |
pg kg | 12 |
dosing regimens | 12 |
urban areas | 12 |
assisted ventilation | 12 |
sum test | 12 |
daily practice | 12 |
mean dose | 12 |
superoxide dismutase | 12 |
urine samples | 12 |
training course | 12 |
hemodynamic data | 12 |
leading causes | 12 |
non parametric | 12 |
cumulative mortality | 12 |
local ethics | 12 |
cardiothoracic surgery | 12 |
administered intravenously | 12 |
transfusion requirement | 12 |
major public | 12 |
systolic pressure | 12 |
clinical pulmonary | 12 |
pulmonary gas | 12 |
icu beds | 12 |
consensus conference | 12 |
frail patients | 12 |
kingdom critical | 12 |
using different | 12 |
one group | 12 |
albumin group | 12 |
severe aki | 12 |
alcohol abuse | 12 |
hip fractures | 12 |
frequently associated | 12 |
fi eld | 12 |
standard treatment | 12 |
surgically treated | 12 |
disease control | 12 |
also studied | 12 |
serious infections | 12 |
showed increased | 12 |
pressure monitoring | 12 |
st january | 12 |
third day | 12 |
found statistically | 12 |
quantitative analysis | 12 |
transcranial doppler | 12 |
estimated using | 12 |
mathematical model | 12 |
late mortality | 12 |
patients reported | 12 |
positive fluid | 12 |
respiratory complications | 12 |
polytraumatized patients | 12 |
wet dry | 12 |
commercially available | 12 |
initial rhythm | 12 |
magnetic resonance | 12 |
national institutes | 12 |
hour period | 12 |
ischemia reperfusion | 12 |
invasive fungal | 12 |
systemic infl | 12 |
lst limitation | 12 |
early albumin | 12 |
still alive | 12 |
significantly shorter | 12 |
recent study | 12 |
first admission | 12 |
time constant | 12 |
mechanical properties | 12 |
cutoff value | 12 |
electronic patient | 12 |
likely due | 12 |
initial blood | 12 |
head injured | 12 |